Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapy

類似資料

• HCV dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy
  著者:: DebRoy, Swati, 等
  出版事項: (2016)
• Understanding silibinin’s modes of action against HCV using viral kinetic modeling
  著者:: Guedj, Jeremie, 等
  出版事項: (2012)
• Silibinin mode of action(s) against HCV: A controversy yet to be resolved
  著者:: Dahari, Harel, 等
  出版事項: (2011)
• Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modeling of HCV kinetics
  著者:: Dahari, Harel, 等
  出版事項: (2014)
• HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients
  著者:: Canini, Laetitia, 等
  出版事項: (2017)